FDA.reportPublic FDA data

BiDil 20 MG / 37.5 MG Oral Tablet

RxCUI
905379
RxNorm name
BiDil 20 MG / 37.5 MG Oral Tablet
Display name
BiDil 20 MG / 37.5 MG Oral Tablet
Full name
BiDil 20 MG / 37.5 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BiDilHYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATEAzurity Pharmaceuticals, Inc.e1e63cd5-d1e4-4af5-bad5-1ad41ea46b002025-11-30Warnings, Adverse reactionsExact identifier
rxcui: 905379

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e1e63cd5-d1e4-4af5-bad5-1ad41ea46b00BiDil 20 MG / 37.5 MG Oral Tablet [PSN] · hydralazine hydrochloride 37.5 MG / isosorbide dinitrate 20 MG Oral Tablet [Bidil] [SBD] · Bidil (hydralazine hydrochloride 37.5 MG / isosorbide dinitrate 20 MG) Oral Tablet [SY] · BiDil 20/37.5 (isosorbide dinitrate / hydralazine HCl) Oral Tablet [SY] · Hydralazine Hydrochloride 37.5 MG / ISDN 20 MG Oral Tablet [Bidil] [SY]513These highlights do not include all the information needed to use BIDIL safely and effectively. See full prescribing information for BIDIL. BIDIL ® (isosorbide dinitrate and hydralazine hydrochloride) tablet, for oral use Initial U.S. Approval: 200520251130